{"filing":{"accession_number":"0001279569-26-000809","cik":"0001683541","ticker":"ACB","company_name":"AURORA CANNABIS INC","form":"6-K","filing_date":"2026-08-19","report_date":"2026-08-19","primary_document":"aurora_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1683541/000127956926000809/aurora_6k.htm"},"events":[{"id":28468,"run_id":26044,"accession_number":"0001279569-26-000809","anchor_item_number":"EX-99.1","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"Aurora Cannabis announces the completion of an acquisition of Internode Pharma Limited and HAP Pharma Limited, UK-based licensed importer/wholesaler and pharmacy operations. The transaction involved a GBP 2.1 million cash payment and is described as \"accretive\" to adjusted EBITDA, providing direct ownership and control of the UK supply chain. This is a material acquisition expanding Aurora's international medical cannabis distribution footprint.","company_name":"AURORA CANNABIS INC","ticker":"ACB","filing_date":"2026-08-19","form":"6-K","submitted_at":null,"items":[{"id":30420,"accession_number":"0001279569-26-000809","item_number":"EX-99.1","item_title":"ex991.htm","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"Aurora Cannabis announces the completion of an acquisition of Internode Pharma Limited and HAP Pharma Limited, UK-based licensed importer/wholesaler and pharmacy operations. The transaction involved a GBP 2.1 million cash payment and is described as \"accretive\" to adjusted EBITDA, providing direct ownership and control of the UK supply chain. This is a material acquisition expanding Aurora's international medical cannabis distribution footprint.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-19T18:28:58.408975+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":30420,"accession_number":"0001279569-26-000809","item_number":"EX-99.1","item_title":"ex991.htm","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"Aurora Cannabis announces the completion of an acquisition of Internode Pharma Limited and HAP Pharma Limited, UK-based licensed importer/wholesaler and pharmacy operations. The transaction involved a GBP 2.1 million cash payment and is described as \"accretive\" to adjusted EBITDA, providing direct ownership and control of the UK supply chain. This is a material acquisition expanding Aurora's international medical cannabis distribution footprint.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-19T18:28:58.408975+00:00","company_name":"AURORA CANNABIS INC","ticker":"ACB","filing_date":"2026-08-19"}]}